Read about the latest insights in skin cancer care with a new whitepaper on advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. View the complimentary resource today!
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...